Senestech Inc
NASDAQ:SNES
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.31
6.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Senestech Inc
SenesTech, Inc. engages in the development and commercialization of a proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. The company is headquartered in Flagstaff, Arizona and currently employs 26 full-time employees. The company went IPO on 2016-12-08. The Company’s product ContraPest, is in the pest control industry in attacking the reproductive systems of both male and female rats. ContraPest is a liquid bait containing the active ingredients four vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest has two active ingredients, including 4-VCD and triptolide. Triptolide is derived from the thunder god vine Tripterygium wilfordii, used in traditional Chinese medicines and other over-the-counter supplements. Triptolide affects the reproductive capacity of both male and female rats. VCD is an occupational chemical that selectively destroys ovarian follicles in rats. The firm also continues to research and develop enhancements to ContraPest that align with its target verticals and other potential fertility control options for additional species.
SenesTech, Inc. engages in the development and commercialization of a proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. The company is headquartered in Flagstaff, Arizona and currently employs 26 full-time employees. The company went IPO on 2016-12-08. The Company’s product ContraPest, is in the pest control industry in attacking the reproductive systems of both male and female rats. ContraPest is a liquid bait containing the active ingredients four vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest has two active ingredients, including 4-VCD and triptolide. Triptolide is derived from the thunder god vine Tripterygium wilfordii, used in traditional Chinese medicines and other over-the-counter supplements. Triptolide affects the reproductive capacity of both male and female rats. VCD is an occupational chemical that selectively destroys ovarian follicles in rats. The firm also continues to research and develop enhancements to ContraPest that align with its target verticals and other potential fertility control options for additional species.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.